These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
213 related items for PubMed ID: 29267766
1. [Molecular characterization of pathogenic bacteria of the respiratory tract in peruvian patients with cystic fibrosis]. Aquino R, Gonzáles E, Samaniego S, Rivera J, Cedeño V, Urbina Y, Diringer B. Rev Peru Med Exp Salud Publica; 2017; 34(3):423-435. PubMed ID: 29267766 [Abstract] [Full Text] [Related]
7. Clinical Strains of Chryseobacterium and Elizabethkingia spp. Isolated from Pediatric Patients in a University Hospital: Performance of MALDI-TOF MS-Based Identification, Antimicrobial Susceptibilities, and Baseline Patient Characteristics. Mirza HC, Tuncer Ö, Ölmez S, Şener B, Tuğcu GD, Özçelik U, Gürsoy NC, Otlu B, Büyükçam A, Kara A, Sancak B. Microb Drug Resist; 2018; 24(6):816-821. PubMed ID: 29227188 [Abstract] [Full Text] [Related]
11. Rapid screening and characterization of bacteria associated with hospital cockroaches (Blattella germanica L.) using MALDI-TOF mass spectrometry. Mehainaoui A, Menasria T, Benouagueni S, Benhadj M, Lalaoui R, Gacemi-Kirane D. J Appl Microbiol; 2021 Mar; 130(3):960-970. PubMed ID: 32737936 [Abstract] [Full Text] [Related]
12. Practical Guidance for Clinical Microbiology Laboratories: Updated guidance for processing respiratory tract samples from people with cystic fibrosis. Saiman L, Waters V, LiPuma JJ, Hoffman LR, Alby K, Zhang SX, Yau YC, Downey DG, Sermet-Gaudelus I, Bouchara J-P, Kidd TJ, Bell SC, Brown AW. Clin Microbiol Rev; 2024 Sep 12; 37(3):e0021521. PubMed ID: 39158301 [Abstract] [Full Text] [Related]
13. Cohort Study of Airway Mycobiome in Adult Cystic Fibrosis Patients: Differences in Community Structure between Fungi and Bacteria Reveal Predominance of Transient Fungal Elements. Kramer R, Sauer-Heilborn A, Welte T, Guzman CA, Abraham WR, Höfle MG. J Clin Microbiol; 2015 Sep 12; 53(9):2900-7. PubMed ID: 26135861 [Abstract] [Full Text] [Related]
14. Improvement of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry identification of difficult-to-identify bacteria and its impact in the workflow of a clinical microbiology laboratory. Rodríguez-Sánchez B, Marín M, Sánchez-Carrillo C, Cercenado E, Ruiz A, Rodríguez-Créixems M, Bouza E. Diagn Microbiol Infect Dis; 2014 May 12; 79(1):1-6. PubMed ID: 24602850 [Abstract] [Full Text] [Related]
16. Discrepancy in MALDI-TOF MS identification of uncommon Gram-negative bacteria from lower respiratory secretions in patients with cystic fibrosis. AbdulWahab A, Taj-Aldeen SJ, Ibrahim EB, Talaq E, Abu-Madi M, Fotedar R. Infect Drug Resist; 2015 May 12; 8():83-8. PubMed ID: 25995646 [Abstract] [Full Text] [Related]
17. The metabolic footprint of the airway bacterial community in cystic fibrosis. Narayanamurthy V, Sweetnam JM, Denner DR, Chen LW, Naureckas ET, Laxman B, White SR. Microbiome; 2017 Jun 30; 5(1):67. PubMed ID: 28666467 [Abstract] [Full Text] [Related]
19. Fungal and Bacterial Diversity of Airway Microbiota in Adults with Cystic Fibrosis: Concordance Between Conventional Methods and Ultra-Deep Sequencing, and Their Practical use in the Clinical Laboratory. Botterel F, Angebault C, Cabaret O, Stressmann FA, Costa JM, Wallet F, Wallaert B, Bruce K, Delhaes L. Mycopathologia; 2018 Feb 30; 183(1):171-183. PubMed ID: 28766039 [Abstract] [Full Text] [Related]